Done The Zacks Analyst Blog Highlights: GOL Linhas Aereas Inteligentes, United Continental Holdings, JetBlue Airways, Southwest Airlines and Copa Holdings By Zacks Equity Research 15 hours ago 0 shares For Immediate Release Chicago, IL July 17, 2014 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the GOL Linhas Aereas Inteligentes S.A. ( GOL - Free Report ), United Continental Holdings Inc. ( UAL - Free Report ), JetBlue Airways Corporation ( JBLU - Free Report ), Southwest Airlines Co. ( LUV - Free Report ) and Copa Holdings SA ( CPA - Free Report ). Today, Zacks is promoting its ''Buy'' stock recommendations.
BLOG: Daddy-Daughter Date Goes Viral | 5NEWSOnline.com
He came to the door to get her with a corsage. Downstairs he opened the passenger side and she got in he put her seatbelt on and they rode to the dance. I drove by the school and when I saw the two of them dancing it brought tears to my eyes.
BlackBerry Suffers a Knockout Punch from Apple-IBM - Analyst Blog - NASDAQ.com
Moreover, profit margin is very high for this business and generally loyal customers are added advantage. The turnaround strategy of the company revolved around its enterprise service business including BBM instant messaging service coupled with cost cutting and sale of underutilized properties. Meanwhile, the signing of a business agreement between former arch rivals, Apple and IBM, under which IBM will develop over 100 applications related to analytics, Big Data, mobile device management and security software, primarily for enterprise users of Apple's iPhone and iPad has jeopardized BlackBerry's turnaround plans. Apple's mobile devices are gaining rapid traction in the enterprise segment and an innovative product from the Apple-IBM entity is likely to be an instant hit among companies which support Bring your Own Device (BYOD) trend. Furthermore, the integration of IBM's state-of-the-art advanced analytics systems into Apple's mobile devices may become a game changer, enabling the corporate sector to significantly enhance efficiency and productivity of their employees which will help them to maximize profit. Additionally, the joint venture will provide secured means for executing business transactions. We remain skeptical about the long-term prospects of BlackBerry.
Repros Gets Additional FDA Guidance for Androxal - Analyst Blog - NASDAQ.com
The FDA also recommended comparing the percentage of men that exhibit sperm 10 million/mL and testosterone in the normal range using Androxal, testosterone gel and placebo at the end of 16 weeks of dosing. Repros is modifying the primary endpoints and statistical analysis plan for ZA-304 and ZA-305 to incorporate the suggestions made by the FDA. However, this will not affect the schedule for study completion. Repros expects to submit a new drug application (NDA) to the FDA for Androxal for the secondary hypogonadism indication by the end of this year. Currently prescribed therapies for secondary hypogonadism include AbbVie Inc. 's ( ABBV ) AndroGel. Repros currently carries a Zacks Rank #3 (Hold).